The Role of the Pharmacist With Cholesterol Management: Focusing on New Guidelines and PCSK9 Inhibitors

Pharmacy TimesAugust 2019 Back to School
Volume 85
Issue 8

Continuing education for managing cholesterol with PCSK9 inhibitors.


Joseph J. Saseen, PharmD, BCPS, BCACP, CLS, Professor and Vice Chair, Department of Clinical Pharmacy; Professor, Department of Family Medicine; University of Colorado Anschutz Medical Campus, Aurora Colorado

Educational Objectives

At the completion of this activity, the participant will be able to:

  • Examine the pathophysiology, complications, and burden associated with hypercholesterolemia
  • Identify updates to guidelines and the appropriate role of PCSK9 inhibitors in the management of hypercholesterolemia
  • Explore various ways that pharmacists can make an impact and provide education for patients with hypercholesteremia to optimize outcomes

Target Audience: Pharmacists

Activity Type: Application

Release Date: August 12, 2019

Expiration Date: August 12, 2020

Estimated Time to Complete Activity: 2.0 hours

Fee: This lesson is offered for free at

Recent Videos
Practice Pearl #1 Active Surveillance vs Treatment in Patients with NETs
© 2024 MJH Life Sciences

All rights reserved.